Fisher Wallace Laboratories nabs $2.5m
Fisher Wallace Laboratories, a provider of prescription wearable technology for the treatment of neuropsychiatric disorders, has secured $2.5 million in funding.
Fisher Wallace Laboratories, a provider of prescription wearable technology for the treatment of neuropsychiatric disorders, has secured $2.5 million in funding.
Copyright PEI Media
Not for publication, email or dissemination